CooperVision ANZ Plastic Neutrality Initiative Earns Highly Commended Recognition at the 2022 Prime Awards
SYDNEY, Australia., November 10, 2022——In recognition of its continued leadership in Sustainability, CooperVision Australia and New Zealand received a 'Highly Commended' Award at the 2022 Prime Awards for their plastic neutrality initiative.
The Prime Awards recognise and celebrate excellence across 20 categories within healthcare communications and the Australian pharmaceutical and life sciences industry.
CooperVision Australia and New Zealand this year launched the plastic neutrality initiative and breakthrough partnership with Plastic Bank, a social enterprise that builds ethical recycling ecosystems in coastal communities, making their range of one-day contact lenses plastic neutral, providing an easy way for customers and patients to create positive change.
For every box of one-day lenses distributed, CooperVision purchases credits that fund the collection and recycling of ocean-bound plastic, equal to the weight of the plastic used in its one-day contact lenses. Plastic Bank collectors in coastal communities receive a premium for the plastic collected, helping provide necessities such as groceries and insurance. In 2022 CooperVision set a global goal to prevent the equivalent of 90 million plastic bottles from reaching the world's oceans.
This recognition reflects only a portion of the company's environmental initiatives focused on saving water and conserving energy; reducing, reusing, and recycling resources; and empowering people within the company and the communities in which it operates.
The company is continuously working to minimise environmental impact and operate more sustainably around the globe as part of broader efforts across CooperCompanies to contribute to the United Nations' Sustainable Development Goals.
For more information, visit coopervision.net.au/plasticneutral.
# # #
About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit https://coopervision.com/.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit https://www.coopercos.com/.
Media Contact
Shannon Morrow, Marketing Communications Manager, CooperVision ANZ
smorrow@au.coopervision.com or 0437866918